Back to Insider Trading View Full Company Profile

FULC

MODERATE

Fulcrum Therapeutics, Inc.

CIK: 0001680581

Strong Sell (70% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Revenue $7.80M
Net Income -$9.72M

Insider Roster (3 total, 3 active)

Insider Buys Sells Net Value Holdings
RA CAPITAL MANAGEMENT, L.P.
OTHER
0 3 -$58.38M
6,145,682 shares
$87.76M
Gould Robert J
OTHER
0 4 -$668K
454,864 shares
$4.88M
Oltmans Curtis Gale
Chief Legal Officer
0 1 -$45K
10,252 shares
$132K

Recent Transactions

SELL Gould Robert J (OTHER)

15,000 shares @ $10.72

$161K

Feb 2, 2026

Conviction: | View SEC Filing →
SELL Gould Robert J (OTHER)

15,000 shares @ $11.87

$178K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Gould Robert J (OTHER)

15,000 shares @ $10.87

$163K

Jan 2, 2026

Conviction: | View SEC Filing →
SELL Oltmans Curtis Gale (Chief Legal Officer)

3,452 shares @ $12.92

$45K

Dec 15, 2025

Conviction: | View SEC Filing →
SELL RA CAPITAL MANAGEMENT, L.P. (OTHER)

2,706,397 shares @ $14.28

$38.65M

Dec 8, 2025

Conviction: | View SEC Filing →
SELL RA CAPITAL MANAGEMENT, L.P. (OTHER)

1,377,020 shares @ $13.33

$18.36M

Dec 8, 2025

Conviction: | View SEC Filing →
SELL RA CAPITAL MANAGEMENT, L.P. (OTHER)

91,722 shares @ $14.98

$1.37M

Dec 8, 2025

Conviction: | View SEC Filing →
SELL Gould Robert J (OTHER)

15,000 shares @ $11.03

$165K

Nov 19, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.